
JD Health International Inc.
JDHIY
Updated: 22/09/2026, 21:36:01
JD Health International Inc., an investment holding firm, oversees an internet-based healthcare platform across the People's Republic of China. The company supplies a comprehensive range of pharmaceutical and health-related products, including over-the-counter and prescription medications, various medical equipment and supplies, along with health supplements and restorative tonics. These are distributed both through direct sales and an extensive online retail pharmacy network. Furthermore, JD Health provides an array of digital healthcare services such as virtual consultations, physician and hospital referrals, preventive health check-ups, genetic analysis, and aesthetic care. It also develops health management and intelligent healthcare technologies, in addition to offering technical and advertising services. The platform also enables access to external medical services, including full medical examinations, cosmetic medical treatments, vaccination appointment scheduling, dental care, and nucleic acid testing. Incorporated in 2018, the company is headquartered in Beijing, China, and functions as a subsidiary of JD Jiankang Limited.
No summaries found.
- Share price
- $5.05
- Market cap
- $16.22B
- Exchange
- OTC
- Currency
- USD
- CEO
- Dong Cao
- Employees
- 5,263
- IPO date
- 04/04/2022
- Beta
- 1.184
- Last dividend
- $0.00
- Day range
- $5.05 – $5.05
- 52-week range
- $4.26 – $9.08
- 1-day performance
- 0.00%
- 1-year performance
- 18.54%
- Current drawdown (1Y)
- -44.38%
- CIK
- N/A
- CUSIP
- 47216G105
- ISIN
- US47216G1058
- Created
- 07/12/2025, 04:50:13
- Last update
- 22/09/2026, 21:36:01
Track JD Health International Inc. with an AI analyst
See which prediction-market events move JDHIY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.